Exelixis (NASDAQ:
EXEL) shares tumbled 52.90% to $1.95 after the company announced its plans to lower around 70% of its workforce. The company reported that its phase 3 pivotal trial of cabozantinib did not meet primary endpoint.
Conns (NASDAQ:
CONN) dropped 28.61% to $32.01 after the company reported weaker-than-expected second-quarter earnings and cut its full-year forecast.
Aastrom Biosciences (NASDAQ:
ASTM) shares dipped 8.53% to $3.54.
Finisar (NASDAQ:
FNSR) shares declined 5.22% to $19.25. Analysts at Jefferies downgraded Finisar from Buy to Hold and lowered the target price from $25 to $19.
Select Income REIT (NYSE:
SIR) shares dropped 5.16% to $26.46. Select Income REIT announced its plans to acquire Cole Corporate Income Trust for $3 billion in a cash and stock deal.
Elbit Imaging (NASDAQ:
EMITF) fell 2.02% to $3.88 after falling 3.04% on Friday.
Newmont Mining (NYSE:
NEM) shares slipped 1.85% to $26.59 after the company reached a tentative deal with the Indonesian government over an export dispute.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
